Answers are grounded in this paper and cite their sources.
Congenital fibrinogen qualitative disorders, including dysfibrinogenemia and hypo-dysfibrinogenaemia, are highly heterogeneous, both in clinical manifestation and for the mutational molecular spectrum driving these disorders. Correlations between phenotype and genotype remain poorly defined. Considerable work lies ahead in order to achieve diagnostic and prognostic precision and subsequently provide targeted management for this rare disease. Here we report the laboratory test, the clinical and molecular characterisation of a family with dysfibrinogenemia.
No takes yet. Share an insight, caveat, or question.
G García-Donas (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: